Linkedin

Category: Blogs

Real World Evidence Conference Sponsorship: Packages, Benefits & Opportunities

Posted on by veridonglobal.dev@gmail.com

The Real World Evidence Conference Sponsorship at Hilton Garden Inn Camden Waterfront Philadelphia, USA scheduled for 08–09 June 2026, is one of the most influential gatherings for healthcare, pharmaceutical, and life sciences professionals. This premier event brings together global industry leaders, payers, researchers, and solution providers to explore the evolving role of real-world evidence in shaping market access and healthcare decision-making. For organizations aiming to increase brand visibility, engage with senior decision-makers, and establish thought leadership, Real World Evidence Conference sponsorship offers unmatched opportunities to make a lasting impact. Whether you are a global pharmaceutical company, a biotech innovator, or a healthcare solutions provider, sponsoring a Real World Evidence Conference allows you to connect with key industry stakeholders and maximize your impact.

Explore all sponsorship opportunities and secure your spot here: Become a Sponsor

Real World Evidence Conference Sponsorship Packages

Choosing the right sponsorship package ensures your organization achieves maximum ROI and visibility. Here are the available packages:

  • Platinum Sponsor – Premium branding, top-tier visibility, and priority access to networking events.
  • Gold Sponsor – Exclusive exposure and opportunities to engage with senior decision-makers.
  • Silver Sponsor – Targeted branding in breakout sessions and conference materials.
  • Bronze Sponsor – Budget-friendly branding opportunities for strategic impact.
  • Conference Exhibitor – Showcase your products and services at dedicated exhibition spaces.
  • Conference Speaking (15 to 30 Minutes) – Demonstrate thought leadership with expert presentations.
  • Networking Partner – Facilitate meaningful connections during curated networking sessions.
  • Lanyard Sponsor – Achieve everyday visibility as attendees wear branded lanyards.
  • Associate Sponsor – Gain recognition as a supporting partner while strengthening your presence.

Benefits of Sponsoring a Real World Evidence Conference

Investing in Real World Evidence Conference sponsorship goes beyond brand exposure. Here’s why leading organizations participate:

  1. Unparalleled Brand Visibility with Tailormade Marketing Plans
    Reach your target audience with customized marketing campaigns across digital, onsite, and post-event channels.
  2. Engage with Senior Decision-Makers
    Connect directly with executives, payers, and industry leaders who drive critical business decisions.
  3. Flexible, Tailored Packages
    Select a package that aligns perfectly with your objectives, budget, and brand strategy.
  4. Lead Generation & ROI-Driven Outcomes
    Generate qualified leads, track engagement, and achieve measurable business results.
  5. Thought Leadership Opportunities
    Position your brand as an authority through speaking slots, panel discussions, and interactive sessions.

Why Real World Evidence Conference Sponsorship Matters

Sponsoring a Real World Evidence Conference is a strategic investment that ensures your organization:

  • Gains credibility and recognition in healthcare and life sciences.
  • Engages with the right audience efficiently.
  • Drives qualified leads and measurable ROI.
  • Strengthens thought leadership in RWE and market access.

With sponsorship packages ranging from Platinum to Associate, there’s a solution for every organization seeking maximum impact.

Don’t miss this opportunity to elevate your brand and connect with decision-makers: Become a Sponsor Today.

 

FPS Pharma Leads the Future of High-Containment Manufacturing at EuroPotent 360 Summit

Posted on by Federica Fazio

As the pharmaceutical industry evolves toward targeted therapies and increasingly potent and complex APIs, process control, precision and proper containment are more critical than ever.

This is why we’re excited to share that FPS Pharma is the Gold Sponsor at the upcoming Veridon Global event 2nd Annual EuroPotent 360 Summit a premier forum where industry leaders, innovators, and change-makers converge to shape the future of healthcare and pharmaceutical technology.

FPS Pharma mission is to ensure the utmost efficiency, safety and compliance in critical pharmaceutical manufacturing processes, especially in handling high-potency active pharmaceutical ingredients (HPAPIs) and antibody-drug conjugates (ADCs). With advanced containment isolators, innovative control systems, and next-level engineering solutions, FPS Pharma is empowering manufacturers to operate at new levels of excellence.

Why FPS Pharma stands out in containment and isolation technology

Pharmaceutical manufacturing increasingly depends on highly controlled systems for handling potent and sterile compounds.

What sets FPS Pharma high-containment isolators apart is not only their performance, but their design philosophy. These systems are engineered with the understanding that containment is not a constraint, but a catalyst. By enabling the safe handling of ultra-potent APIs, they unlock new possibilities in drug development, allowing manufacturers to explore new types of chemistry and to scale up with confidence. These custom isolators incorporate features such as closed transfer systems (RTPs, SBVs and others), automated cleaning (CIP/WIP), sterilization-in-place (SIP), real-time monitoring, and also advanced features such as robotic and voice-controlled systems. Every element is engineered to minimize contamination risks, maximize precision, optimize operational efficacy, and ensure compliance with the most stringent global standards.

For toxic applications, FPS Pharma develops negative-pressure custom isolators with turbulent airflow, designed to achieve containment levels from 10 µg/m3 to single-digit nanogram levels and below (from OEB 4 up to OEB 7).

Supporting next-generation HPAPI and ADC manufacturing

ADCs are continuously evolving and increasing their payload (cytotoxic drug) potency to increase their therapeutic efficacy. This leads to their success and to its rapid growth and to an increase in containment complexity. To meet this challenge, FPS Pharma has pioneered containment systems like OEB 7 isolators, representing the new frontier in ultra-potent API containment, which guarantee single-digit nanogram containment down to 1 ng/m3. Isolators).

FPS Pharma’s custom containment solutions can seamlessly integrate all the process phases and technologies, such as sampling and dispensing, reactor charging, filtration and drying, ANFD discharge, milling, micronization, filling, packaging and quality control, and customer’s equipment. This application-driven approach helps customers simplify process steps, minimize operator exposure risks, optimize workflow and ensure utmost product quality.

Innovation that improves both compliance and operational efficiency

In addition to FPS Pharma isolator technologies and micronization systems, FPS Pharma offers advanced glove leak testing devices such as GloveXpert, its patented wireless glove leak tester for isolators and RABS. It performs reliable and repeatable integrity testing on both gloves and glove ports using the positive pressure decay method, in full compliance with UNI EN ISO 14644-7.

Designed for speed, safety and ease of use, GloveXpert can complete a test in 4 to 9 minutes, perform up to 120 test cycles on a single charge, detect holes as small as 100 microns, and supports features such as RFID, Wi-Fi connectivity, and many other features which make glove testing easy, ultra-accurate and fast. It reflects FPS Pharma’s broader commitment to combining smart engineering with practical, inspection-ready solutions for pharmaceutical operations.

Looking Ahead: FPS Pharma at Veridon Global

As Veridon Global brings together leaders from across healthcare, life sciences, and technology, FPS Pharma’s role as Gold Sponsor underscores its strategic vision: to help the industry innovate boldly while operating within the highest standards of safety and compliance. From high-containment isolators to next-generation API manufacturing solutions, FPS Pharma continues to push boundaries and redefine what’s possible in pharmaceutical production.

We look forward to meaningful conversations at 2nd Annual EuroPotent 360 Summit — connecting, learning, and co-creating safer, smarter pharmaceutical futures. Stay tuned for more insights and highlights from the event!

Become a Sponsor at the Real World Evidence and Market Access Conference USA 2026

Posted on by veridonglobal.dev@gmail.com

In a healthcare landscape driven by real-world evidence (RWE), pricing innovation, and faster patient access, the ability to connect with the right stakeholders is more valuable than ever. The Real World Evidence and Market Access Conference USA Edition 2026, also known as the Evidence 360 Summit USA, is designed to bring together the very people shaping these decisions.

If your organization is looking to increase visibility, build credibility, and generate high-value partnerships, becoming a sponsor is not just an option—it’s a strategic move.

Secure your Sponsorship today at: https://veridonglobal.com/upcoming-conferences/2nd-annual-evidence-360-summit-usa-edition/become-a-sponsor-2nd-annual-evidence-360-summit-usa-edition/

Why the Evidence 360 Summit USA 2026 Matters

Scheduled for June 8–9, 2026, in Philadelphia, this summit is a premier platform focused on how RWE is transforming market access, pricing, and reimbursement strategies in the U.S. healthcare system.

It brings together:

  • Pharmaceutical and biotech leaders
  • Payers and policy makers
  • HEOR and RWE experts
  • Digital health and data innovators

As the U.S. market evolves with value-based care models, AI-driven evidence generation, and stricter pricing regulations, events like this become critical spaces for collaboration and decision-making.

Why Become a Sponsor?

Sponsoring the Evidence 360 Summit USA 2026 goes far beyond brand exposure—it places your organization at the center of industry conversations and business opportunities.

1. Position Your Brand as an Industry Leader

Sponsors gain opportunities to:

  • Deliver keynote or featured presentations
  • Join expert panel discussions
  • Showcase real-world case studies

This allows your organization to demonstrate expertise and influence how the industry evolves.

2. Direct Access to Decision-Makers

The summit attracts senior-level professionals and final decision-makers, making every interaction valuable.

With sponsorship, you can:

  • Participate in curated one-to-one meetings
  • Build relationships with key stakeholders
  • Engage in high-level networking sessions

These are not just conversations—they are opportunities for real business growth.

3. Generate High-Quality, Pre-Qualified Leads

Unlike traditional marketing channels, this event delivers:

  • A highly targeted audience
  • Professionals actively seeking solutions
  • Face-to-face engagement opportunities

This results in better lead quality and higher conversion potential.

4. Showcase Your Solutions in Action

Sponsors typically receive exhibition opportunities to:

  • Demonstrate products and services
  • Conduct live demos
  • Interact directly with potential clients

This hands-on approach builds trust, credibility, and faster decision-making.

5. Maximize Brand Visibility Before, During, and After the Event

Your brand is featured across:

  • Event marketing campaigns and email promotions
  • Social media and digital channels
  • On-site branding and conference materials

This ensures continuous exposure to a highly relevant audience.

Sponsorship Opportunities and Packages

While specific packages for the 2026 USA edition follow a tailored structure, typical sponsorship tiers include:

Platinum Sponsor

  • Premium branding across all channels
  • Prime speaking slot in the main agenda
  • Maximum networking and meeting opportunities
  • Exhibition booth and delegate passes

Gold Sponsor

  • Strong visibility and presentation opportunities
  • Dedicated one-to-one meetings
  • Exhibition space and marketing exposure

Silver Sponsor

  • Cost-effective entry with branding and networking access
  • Exhibition opportunities
  • Participation in key sessions

Across Veridon Global events, sponsorship packages often include speaking slots, exhibition booths, one-to-one meetings, social media promotion, and post-event attendee access, ensuring measurable ROI.

Who Should Sponsor This Conference?

This opportunity is ideal for organizations involved in:

  • Pharmaceuticals and biotechnology
  • Real-world data and analytics
  • Market access and pricing strategy
  • HEOR and value-based healthcare
  • Digital health and AI-driven solutions

If your goal is to influence healthcare decision-making and expand your presence in the U.S. market, this is the right platform.

What Makes This Event Stand Out?

The Evidence 360 Summit USA is not just another healthcare conference. It is a focused, high-impact event that emphasizes:

  • Real-world applications of RWE
  • Practical solutions to market access challenges
  • Collaboration between industry, payers, and regulators

It is designed to turn insights into action, making it highly valuable for sponsors seeking real outcomes.

Long-Term Value of Sponsorship

Beyond immediate visibility, sponsoring this event helps you:

  • Build long-term industry relationships
  • Strengthen brand authority
  • Stay aligned with emerging trends and regulations

In a competitive and rapidly evolving healthcare environment, these advantages contribute to sustained growth and market leadership.

Final Thoughts

The Real World Evidence and Market Access Conference USA Edition 2026 is where data meets decision-making and innovation meets access.

Becoming a sponsor allows you to:

  • Lead industry conversations
  • Connect with key stakeholders
  • Showcase your expertise
  • Drive real business results

If your organization is serious about making an impact in RWE, pricing, and market access, this is where you need to be.

 

How to Register for Real World Evidence and Market Access Conference 2026 in USA?

Posted on by veridonglobal.dev@gmail.com

To register for a real world evidence conference, choose a relevant event like the Evidence 360 Summit USA 2026, select your pass type, complete the registration form, and confirm early to secure full access and networking opportunities.

Registering for a real world evidence conference is an important step for professionals in pharma, biotech, and healthcare who want to stay ahead in data-driven decision-making. The right event provides insights into real-world data, pricing strategies, and market access while offering valuable networking opportunities.

If you’re looking for the best real world evidence conference in the USA in 2026, the
2nd Annual EVIDENCE 360: RWE, Pricing and Market Access Summit USA Edition is a leading choice.

Location: Hilton Garden Inn Camden Waterfront, Philadelphia
Date: 08–09 June 2026

Why attend a real world evidence conference in 2026?

A real world evidence conference helps professionals:

  • Understand how real-world data supports regulatory and payer decisions
  • Explore pricing and reimbursement strategies
  • Learn how AI is transforming evidence generation
  • Connect with industry leaders and decision-makers

Events like Evidence 360 bring together pharma, biotech, payers, and solution providers, making them highly valuable for strategic growth.

Step 1: Choose the right real world evidence conference

Before registering, ensure the event matches your goals. A high-quality real world evidence conference should include:

  • Real-world data and HEOR insights
  • Market access and pricing discussions
  • Regulatory and policy perspectives
  • AI and digital health innovations

The Evidence 360 Summit is specifically designed to address these critical areas.

Step 2: Select the right registration pass

Choosing the correct pass ensures you get the most relevant access and networking opportunities.

Pharma & Biotech Pass (Free)

Ideal for pharma and biotech professionals.

Includes:

  • Full conference access (one attendee)
  • Access to networking sessions
  • Lunch and refreshments
  • Event e-brochure
  • E-certificate of attendance

Vendor Delegate Standard Pass – $1,499

Best for individual vendors and solution providers.

Includes:

  • One delegate pass
  • Full conference access
  • Networking sessions
  • Lunch and refreshments
  • Event e-brochure

Vendor Delegate Group Pass – $2,999

Suitable for teams attending together.

Includes:

  • Three delegate passes
  • Full conference access
  • Networking sessions
  • Lunch and refreshments
  • Event e-brochure

Networking Partner – $3,500

Designed for companies focused on partnerships and business development.

Includes:

  • Two delegate passes
  • Full conference access
  • Networking sessions
  • Lunch and refreshments
  • Three one-to-one meetings with selected attendees

Step 3: Complete your registration

To register for a real world evidence conference, follow these steps:

  1. Visit the official registration page
  2. Choose your pass category
  3. Fill in your professional details
  4. Confirm your registration and complete payment (if required)

A smooth and transparent registration process reflects a well-organized conference experience.

Registration at: https://veridonglobal.com/upcoming-conferences/2nd-annual-evidence-360-summit-usa-edition/2nd-annual-evidence-360-usa-registeration/

Step 4: Register early for better opportunities

Early registration helps you:

  • Secure limited free pharma passes
  • Access better networking opportunities
  • Plan meetings and travel in advance

Top conferences like Evidence 360 attract senior-level professionals, so early action is important.

Step 5: Prepare after registration

Once registered, maximize your experience by:

  • Reviewing the agenda in advance
  • Shortlisting key sessions
  • Identifying important speakers
  • Scheduling meetings early

This ensures you gain real insights and meaningful connections.

Why Evidence 360 is a benchmark real world evidence conference

The 2nd Annual EVIDENCE 360: RWE, Pricing and Market Access Summit USA Edition sets a strong benchmark because it offers:

  • A focused agenda on RWE, pricing, and market access
  • Senior-level attendees and industry experts
  • Structured networking opportunities
  • One-to-one business meetings
  • Flexible registration options

This combination makes it one of the top real world evidence conferences in the USA in 2026.

Final thoughts

Registering for a real world evidence conference in 2026 should be a strategic decision. From selecting the right event to choosing the correct pass, each step impacts the value you gain.

The Evidence 360 Summit provides the ideal mix of insights, networking, and practical learning, making it a must-attend event for professionals looking to stay competitive in healthcare and life sciences.

 

2nd Annual HPAPI Summit 2026 – When and Where?

Posted on by veridonglobal.dev@gmail.com

What is the 2nd Annual HPAPI Summit 2026?

The 2nd Annual HPAPI Summit 2026 is a leading European conference focused on the development, manufacturing, safety, and containment of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). Targeted at pharmaceutical professionals, CDMOs, containment engineers, EHS specialists, and quality managers, this summit brings together industry experts to share best practices, regulatory updates, and cutting‑edge technologies for handling potent APIs safely and efficiently.

When and where is the 2nd Annual HPAPI Summit 2026?

The 2nd Annual HPAPI Summit 2026 will take place on:

20–22 May 2026

Venue:

Radisson Blu Hotel Milan

Via Villapizzone 24, Milan, 20156, Italy This centrally located hotel offers modern conference facilities, excellent networking spaces, and easy access to Milan’s international transport links, making it a convenient hub for professionals traveling from across Europe and beyond.

Why attend the 2nd Annual HPAPI Summit 2026?

  • Deep‑dive sessions on HPAPI development, high‑potency formulations, and containment strategies.
  • Regulatory insights into EU and global standards for handling potent compounds safely.
  • Engineering and containment showcases featuring isolators, RABS, cleanrooms, and closed‑system technologies.
  • Networking opportunities with CDMOs, equipment suppliers, regulatory consultants, and pharma leaders.
  • Whether you work in R&D, manufacturing, validation, safety, or quality, the HPAPI Summit 2026 is designed to help you reduce risk, improve efficiency, and stay compliant in a rapidly evolving HPAPI landscape.

How to register for the upcoming HPAPI Conference in Europe?

If you want to attend the 2nd Annual HPAPI Summit 2026 in Milan, you can register through the official event registration portal.

Registration links:

2nd Annual HPAPI Summit 2026 registration:

https://veridonglobal.com/upcoming-conferences/2nd-annual-europotent-360-summit/pharma-cleaning-and-containment-summit-2026-registration/

On the registration page you will typically find:

  • Delegate ticket options (early‑bird, standard, group, and student/academic rates).
  • Agenda and speaker list previews.
  • Networking and sponsorship opportunities for companies and service providers.
  • Hotel and travel information for international attendees.

We recommend registering early to secure your preferred pass type and to benefit from lower‑tier pricing where available.

    Best HPAPI and High Potent Pharmaceutical Conference in Europe

    Posted on by veridonglobal.dev@gmail.com

    Highly Potent Active Pharmaceutical Ingredients (HPAPIs) are critical components used in advanced drug development, especially in oncology and targeted therapies. As the demand for high-potency medicines grows, pharmaceutical professionals are turning to specialized industry events such as the EuroPotent 360 Summit to explore innovations in containment technologies, safety practices, and regulatory compliance.

    The pharmaceutical industry is rapidly advancing with the increasing use of Highly Potent Active Pharmaceutical Ingredients (HPAPIs) in modern drug development. These compounds are widely used in the treatment of complex diseases such as cancer, autoimmune disorders, and other targeted therapies. Because HPAPIs are extremely powerful even in very small doses, they require specialized manufacturing environments, strict safety measures, and advanced containment technologies.

    As global pharmaceutical companies expand their pipelines of potent drugs, the need for collaboration, innovation, and regulatory knowledge has become more important than ever. Industry conferences dedicated to HPAPI manufacturing and containment systems provide valuable opportunities for professionals to learn about emerging technologies, safety strategies, and regulatory requirements.

    One of the most anticipated industry events addressing these topics is the EuroPotent 360 Summit organized by Veridon Global, widely recognized as the best HPAPI conference in Europe 2026 for professionals working in high-potency pharmaceutical manufacturing and containment solutions.

    Understanding the Importance of HPAPIs in Modern Medicine

    Highly Potent Active Pharmaceutical Ingredients are compounds that produce strong pharmacological effects at very low concentrations. These ingredients are commonly used in specialized therapeutic areas where high potency and targeted drug delivery are essential.

    In recent years, HPAPIs have become increasingly important in pharmaceutical research and production due to several key factors:

    • Growth of oncology drugs and targeted cancer therapies
    • Increasing demand for antibody-drug conjugates (ADCs)
    • Development of highly specialized biologics and small-molecule drugs
    • Expansion of personalized medicine approaches

    However, the manufacturing and handling of HPAPIs present unique challenges. Even minimal exposure can pose health risks to workers if appropriate containment systems are not implemented. As a result, pharmaceutical companies must invest in advanced facilities, safety protocols, and regulatory compliance strategies.

    Industry conferences focusing on HPAPI technologies help professionals stay informed about these evolving challenges and solutions.

    EuroPotent 360 Summit by Veridon Global

    The EuroPotent 360 Summit is a specialized pharmaceutical conference that focuses on the entire lifecycle of highly potent compounds, including development, containment, manufacturing, and regulatory compliance.

    The event is organized by Veridon Global, a global conference organizer known for hosting industry-focused events that bring together pharmaceutical leaders, technology providers, and regulatory experts.

    Event Details

    • Conference: EuroPotent 360 Summit
    • Dates: 20–22 May 2026
    • Location: Milan, Italy
    • Venue: Radisson Blu Hotel Milan

    The conference provides a platform for global experts to discuss practical strategies for managing high-potency pharmaceutical ingredients safely and efficiently.

    Participants will gain insights into the latest developments in containment engineering, occupational safety, regulatory compliance, and pharmaceutical manufacturing technologies.

    Key Topics Covered at the EuroPotent 360 Summit

    The EuroPotent 360 Summit focuses on several important areas related to HPAPI production and management. The agenda is designed to provide practical solutions and industry insights for pharmaceutical professionals.

    1. HPAPI Containment Technologies

    Containment systems play a critical role in preventing exposure to highly potent compounds. Experts at the summit will present new technologies such as:

    • Advanced isolator systems
    • Barrier containment technologies
    • Closed transfer systems
    • High-performance filtration solutions

    These innovations help pharmaceutical companies maintain safe working environments while ensuring product integrity.

    2. Facility Design for High-Potency Manufacturing

    Designing facilities that handle HPAPIs requires careful planning and specialized engineering. The conference will explore best practices in facility design, including:

    • Segregated manufacturing areas
    • Controlled airflow systems
    • Containment laboratories
    • Integrated monitoring technologies

    These design strategies are essential for preventing cross-contamination and maintaining compliance with international regulations.

    3. Cross-Contamination Prevention

    Cross-contamination is one of the most critical challenges in multiproduct pharmaceutical facilities. The EuroPotent 360 Summit will provide insights into:

    • Cleaning validation strategies
    • Risk-based contamination control approaches
    • Advanced monitoring and testing techniques

    Industry experts will also share case studies demonstrating how pharmaceutical companies successfully manage contamination risks in complex manufacturing environments.

    4. Regulatory Compliance and Industry Guidelines

    Regulatory authorities across the world continue to strengthen safety requirements for handling highly potent compounds. The summit will address regulatory expectations and compliance strategies for pharmaceutical organizations operating in global markets.

    Topics include:

    • Good Manufacturing Practice (GMP) compliance
    • Regulatory inspection readiness
    • Risk-based containment frameworks
    • Occupational exposure limits (OELs)

    These sessions help organizations stay aligned with international regulatory standards.

    5. Occupational Safety and Exposure Monitoring

    Worker safety is a critical priority in facilities that handle potent pharmaceutical compounds. The conference will highlight modern exposure monitoring systems and protective technologies designed to protect employees.

    Sessions will discuss:

    • Environmental monitoring systems
    • Worker exposure assessment
    • Personal protective equipment strategies
    • Engineering controls for HPAPI containment

    These approaches help ensure safe operations across pharmaceutical manufacturing environments.

    Networking and Industry Collaboration

    In addition to technical presentations, the EuroPotent 360 Summit offers valuable networking opportunities for professionals across the pharmaceutical ecosystem.

    Participants can connect with:

    • Pharmaceutical manufacturers
    • Biotechnology companies
    • Contract development and manufacturing organizations (CDMOs)
    • Engineering and containment technology providers
    • Regulatory and compliance specialists

    These interactions create opportunities for collaboration, partnerships, and knowledge exchange that can drive innovation in the pharmaceutical sector.

    Why Milan Is a Key Destination for Pharmaceutical Conference

    Milan has become an important hub for international pharmaceutical events due to its strong biotechnology ecosystem and strategic location in Europe. The city hosts numerous scientific conferences and industry gatherings that attract professionals from around the world.

    Milan offers:

    • Excellent international connectivity
    • Advanced conference infrastructure
    • A thriving pharmaceutical and biotechnology industry
    • Access to leading research institutions and universities

    These advantages make Milan an ideal location for global industry events such as the EuroPotent 360 Summit.

    Who Should Attend the EuroPotent 360 Summit?

    The conference is designed for professionals involved in the research, development, and manufacturing of highly potent pharmaceutical compounds.

    Key attendees include:

    • Pharmaceutical manufacturing executives
    • Process engineers and facility designers
    • Environmental health and safety (EHS) specialists
    • Quality assurance and quality control professionals
    • Regulatory affairs experts
    • Biotechnology researchers
    • Containment technology providers

    For these professionals, the summit provides valuable insights into emerging technologies and industry best practices.

    Conclusion

    The growing demand for high-potency medicines has transformed the pharmaceutical manufacturing landscape. As companies continue to develop targeted therapies and complex drugs, the need for advanced containment strategies, regulatory compliance, and innovative technologies will only increase.

    Industry events like the EuroPotent 360 Summit play a crucial role in helping professionals stay informed and connected. By bringing together experts from across the pharmaceutical value chain, the conference encourages collaboration and knowledge sharing that drives progress in HPAPI manufacturing. For professionals looking to stay ahead in this rapidly evolving field, the EuroPotent 360 Summit stands out as the best HPAPI conference in Europe 2026, offering valuable insights, networking opportunities, and practical solutions for the future of high-potency pharmaceutical production.

    FAQ Section:

    1. What is an HPAPI conference?
    An HPAPI conference is an industry event focused on highly potent active pharmaceutical ingredients, covering topics such as containment technologies, regulatory compliance, occupational safety, and high-potency drug manufacturing.

    2. Why are HPAPI conference important for the pharmaceutical industry?
    HPAPI conferences help professionals stay updated on the latest developments in containment systems, manufacturing technologies, safety protocols, and global regulatory requirements for handling highly potent pharmaceutical compounds.

    3. Where is the EuroPotent 360 Summit held?
    The EuroPotent 360 Summit is held in Milan, Italy, bringing together pharmaceutical professionals and industry experts from across Europe and other regions.

    4. Who should attend an HPAPI conference?
    HPAPI conferences are ideal for pharmaceutical manufacturers, containment engineers, regulatory affairs specialists, EHS professionals, quality assurance experts, and biotechnology researchers working with potent compounds.5. What topics are covered at the EuroPotent 360 Summit?
    The summit covers topics such as HPAPI containment technologies, facility design, cross-contamination control, occupational safety, and regulatory compliance for highly potent pharmaceutical manufacturing.

    HPAPI Conference: Who Will Benefit the Most?

    Posted on by veridonglobal.dev@gmail.com

    The HPAPI (Highly Potent Active Pharmaceutical Ingredients) Conference, often referred to as the HPAPI Conference, is a focused platform designed for professionals working at the forefront of high-potency drug development and manufacturing. With increasing regulatory scrutiny and growing demand for specialized containment and safety practices, the HPAPI Conference brings together experts who are directly involved in handling potent compounds across the pharmaceutical and biotech industries.

    But who exactly will benefit the most from attending? Let’s break it down.

    Pharma & Biotech Professionals in Critical Functions

    The conference is especially valuable for professionals working in highly specialized domains where precision, safety, and compliance are non-negotiable.

    1. Cleaning Validation Experts

    Professionals responsible for cleaning validation will gain insights into the latest strategies for ensuring cross-contamination control, setting acceptable limits, and meeting evolving regulatory expectations.

    2. Containment Specialists

    Those working with containment systems will benefit from discussions on advanced technologies, facility design considerations, and real-world case studies on handling HPAPIs safely.

    3. HPAPI Manufacturing Teams

    From process development to large-scale production, manufacturing professionals will learn best practices to improve efficiency while maintaining strict safety standards.

    4. Pharma Engineering Professionals

    Engineers involved in equipment design, facility upgrades, and process optimization will gain valuable knowledge on integrating containment and safety into engineering solutions.

    5. Quality & Compliance Professionals

    For those ensuring adherence to global standards, the conference offers updates on regulatory guidelines, inspection readiness, and quality risk management specific to HPAPI environments.

    6. Maintenance Teams

    Maintenance professionals play a critical role in ensuring equipment reliability and containment integrity. Sessions will highlight preventive maintenance strategies and safe intervention practices.

    7. EHS (Environment, Health & Safety) Professionals

    EHS leaders will benefit from sessions focused on worker safety, exposure control, and building a strong safety culture within high-potency facilities.

    8. Occupational Hygiene Experts

    Understanding and controlling workplace exposure is key. Attendees will gain insights into monitoring techniques, exposure limits, and risk mitigation strategies.

    9. Toxicologists

    Toxicology professionals, especially senior toxicologists, will find value in discussions around occupational exposure limits (OELs), hazard classification, and risk assessment frameworks.

    10. Risk Assessment Specialists

    Experts responsible for identifying and mitigating risks will benefit from practical approaches to risk-based decision-making in HPAPI operations.

    11. Regulatory Affairs Professionals

    Keeping up with global regulatory expectations is crucial. This conference provides updates and interpretations of guidelines impacting HPAPI manufacturing and handling.

    12. Facility Design Experts

    Professionals involved in designing or upgrading facilities will gain insights into containment-driven design, airflow strategies, and regulatory-compliant layouts.

    13. CMO/CDMO Operations Teams

    Contract manufacturers and development organizations will learn how to align their operations with client expectations while maintaining safety, compliance, and efficiency.

    Leadership & Decision Makers

    Beyond technical roles, the HPAPI Conference is highly beneficial for senior leadership and decision-makers who shape strategy and investments.

    • Vice Presidents
    • Directors
    • Heads of Department
    • Senior Managers & Managers
    • Senior Toxicologists

    These professionals will benefit from high-level discussions on industry trends, regulatory shifts, and future-ready strategies for HPAPI handling and manufacturing.

    Why Attend?

    Attending the HPAPI Conference is not just about knowledge sharing—it’s about staying ahead in a rapidly evolving industry. Participants will:

    • Gain practical insights from real-world case studies
    • Learn about latest technologies and innovations
    • Understand regulatory expectations and compliance strategies
    • Network with industry leaders and peers
    • Discover solutions to current operational challenges

    Join industry leaders shaping HPAPI safety at: https://veridonglobal.com/upcoming-conferences/2nd-annual-europotent-360-summit/pharma-cleaning-and-containment-summit-2026-registration/

    Final Thoughts

    The HPAPI Conference is a must-attend event for anyone involved in high-potency pharmaceutical operations. Whether you are working in technical roles like cleaning validation, toxicology, and engineering, or leading teams as a senior decision-maker, the conference offers targeted value tailored to your responsibilities.

    If your work touches HPAPI at any level, this is where you gain the knowledge, connections, and strategies to move forward with confidence.

    Best Real World Evidence Conference in USA 2026: Pricing and Market Access

    Posted on by veridonglobal.dev@gmail.com

    At the forefront of this transformation, the conference will bring together leaders from pharma, biotech, payers, regulators, HTA bodies, and digital health to explore innovative approaches to evidence generation and utilization.

    Key Themes at Real World Evidence Conference USA 2026

    1. The Evolving Role of RWE in U.S. Market Access and Reimbursement

    • The Real World Evidence Conference USA 2026 will highlight how RWE is becoming central to payer and regulatory decision-making
    • Increased use of RWE to complement clinical trial data and demonstrate real-world effectiveness
    • Growing influence of RWE in label expansion and lifecycle management
    • Transition toward value-based reimbursement models supported by real-world outcomes

    2. Payer Expectations: Evidence, Value, and Outcomes

    • Insights at the Real World Evidence Conference USA 2026 will address evolving payer demands
    • Stronger emphasis on outcomes-based evidence and cost-effectiveness
    • Role of RWE in shaping formulary inclusion and reimbursement decisions
    • Aligning clinical outcomes with economic value for successful payer negotiations

    3. Real-World Data Integration into HEOR and Regulatory Strategy

    • Discussions at the Real World Evidence Conference USA 2026 will explore RWD integration into HEOR frameworks
    • Strengthening regulatory submissions with real-world insights
    • Bridging the gap between controlled trials and real-world patient populations
    • Leveraging longitudinal data for comparative effectiveness and safety analysis

    4. Leveraging Digital Tools, AI, and Decentralized Data Sources

    • The Real World Evidence Conference USA 2026 will showcase innovations in AI and digital health
    • Use of machine learning to analyze large, complex datasets
    • Integration of EHRs, wearables, and patient-reported outcomes
    • Rise of decentralized trials and their impact on evidence generation
    • Enhancing data quality and interoperability through advanced technologies

    5. Case Studies: Successful RWE-Driven Access Pathways

    • The Real World Evidence Conference USA 2026 will feature real-world success stories
    • Examples of therapies achieving faster market access using RWE
    • Innovative pricing and reimbursement models based on outcomes
    • Cross-functional collaboration between stakeholders
    • Key lessons from successful payer engagement strategies

    Why Attend the Real World Evidence Conference USA 2026?

    • Stay Ahead of Industry Trends: Understand how RWE is transforming access and pricing
    • Gain Practical Insights: Learn from real-world case studies and expert-led discussions
    • Network with Leaders: Connect with decision-makers across pharma, biotech, and payer organizations
    • Drive Strategic Impact: Apply insights to improve evidence generation and market access strategies

    Who Should Attend?

    • Market Access and Pricing Professionals
    • HEOR and RWE Experts
    • Regulatory Affairs Specialists
    • Payers and Health Plan Executives
    • Digital Health Innovators
    • Pharma and Biotech Leaders

    Register here: https://veridonglobal.com/upcoming-conferences/2nd-annual-evidence-360-summit-usa-edition/2nd-annual-evidence-360-usa-registration/

    ToxiProofAI: Predictive Safety Intelligence for Safer Drug Development

    Posted on by veridonglobal.dev@gmail.com

    ToxiProofAI is redefining how drug discovery teams predict, monitor, and mitigate safety risks across the drug development lifecycle.

    Built specifically for complex biological therapies, the platform integrates multi-omics, real-world toxicology data, and advanced machine learning to deliver early, actionable insight into potential immune-related adverse events (irAEs) and off-target liabilities. By detecting subtle biological patterns that conventional tools often miss, ToxiProofAI helps researchers design safer modalities, prioritize the right candidates, and avoid costly late-stage surprises.

    During clinical development, ToxiProofAI supports patient selection, dose optimization, and early detection of toxicity signals, ultimately de-risking trials and accelerating time to meaningful clinical readouts. By transforming safety assessment from a reactive process into a predictive, data-driven capability, ToxiProofAI empowers organizations to advance innovative drugs, such as IO therapies with greater confidence, speed, and precision.

    Q&A Immuno-Oncology and Biomarker Summit London: Amit from Bioflares

    Posted on by veridonglobal.dev@gmail.com

    1. In your view, what are the most significant recent trends and advancements in immuno-oncology and biomarker science — particularly those that are reshaping how we discover, develop, and evaluate cancer therapies?

    Bright red-shifted and colour-shifting near-infrared bioluminescence systems have been developed which are as versatile as standard the firefly bioluminescence system but can light two types of cell or gene pathway simultaneously in vivo, e.g. in cancer (like T-cell CAR research), stem-cell research, mRNA technologies, gene therapy and countless other biomedical fields, non-invasively and longitudinally with greater quantifiability and better imaging rendering than ever before.

    2️. Without giving too much away, what key takeaways should our audience anticipate from your presentation — and how might these insights contribute to accelerating clinical impact in IO/ biomarker development?

    We have developed new brighter dual-colour near infrared enzymes that utilise infraluciferin to mark two types of cell or gene that can be imaged simultaneously in vitro and animals using standared imaging equipment. The output of our new enzymes equals the light output of bright analog aminoluciferin and we are developing even brighter variants, and those that allow triple parameter bioluminescence imaging in vitro and in vivo.